Table 1.
Fit Parameters from Equation 2 | Fit Parameters from Equation 3 | |||
---|---|---|---|---|
Allosteric Response | ||||
Commercial Name | Commercial Name | |||
Kix (mM) | Qax | Kix (mM) | ||
L-Ala | 0.33±0.01 | 0.100±0.001 | ||
L-Phe | 3.9±0.3 | 0.39±0.01 | ||
Carboxyl modifications | ||||
L-alanine methyl esterb | 1.90±0.05 | 0.120±0.002 | Ethanolamineb | 50±20 |
Ethylamineb,c | 40±10 | |||
Isopropylamineb,c | 25±2 | |||
L-alaninolb,c | 25±1 | |||
Butylamineb,c | —a | |||
Amino modifications | ||||
N-methyl-L-alab | 1.1±0.2 | 0.16±0.01 | Propionic Acidb,c | —a |
L-Pro | 1.40±0.04 | 0.063±0.001 | N-formyl-L-alab,c | —a |
N-acetyl-L-alab,c | —a | |||
Chiral carbon modifications | ||||
D-alanineb | 10±2 | 0.37±0.02 | D-phenylalanineb | —a |
2-aminoisobutyric acidb | 11±2 | 0.16±0.01 |
S(+)-2-amino-2-methyl-3- phenyl-propionic acidb |
—a |
Side Chain modifications | ||||
Glyb | 23±2 | 0.26±0.01 | L-homoserine | 10±4 |
L-Cys | 0.101±0.003 | 0.124±0.002 | L-Ilee | 31±8 |
L-Ser | 4.6±0.4 | 0.24±0.01 | L-norvaline | 29±3 |
L-(+)-2,3-diaminopropionic acid | 8±3 | 0.15±0.05 | L-Asn | —a |
L-(+)-2-aminobutyric acid (2AB) | 0.43±0.02 | 0.05±0.01 | L-Asp | —a |
L-Val | 7.6±0.4 | 0.090±0.004 | L-Leu | —a |
L-Thr | 19.6±0.7 | 0.160±0.003 | L-Glu | —a |
L-Met | 21±2 | 0.35±0.01 | L-norleucine | —a |
O-methyl-L-tyr | 3.8±0.6 | 0.20±0.04 | 2-aminoheptanoic acid | —a |
2-aminocaprylic acid | —a | |||
L-His | —a | |||
L-Arg | —a | |||
L-Lys | —a | |||
3-cyclohexyl-L-alanine | —a | |||
(S)-(+)-2-phenylglycine | —a | |||
4-nitro-L-phenylalanine | —a | |||
L-homophenylalanine | —a | |||
L-Tyr | —a | |||
L-Trp | —a |
Ka-PEP was not responsive to the amino acid analogue within the working concentration defined in Materials and Methods.
Corrected using H476L as described in supporting information
Binding tested by competition with Ala binding. When no Kix value is listed, no competitive binding was detected.